Oculus Innovative Sciences Receives Chinese SFDA Regulatory Approval of Microcyn(R) Technology Mar 27, 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers Mar 17, 2008
Oculus Innovative Sciences Announces Additional Phase II Data for Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Mar 14, 2008
Oculus Innovative Sciences Announces Acceptance of Three Abstracts on the use of Microcyn(R) Technology in Diabetic Foot Ulcers by DFCon 08 Mar 12, 2008
Oculus Innovative Sciences to Announce Additional Phase II Data and Data from Two Recent International Studies at DFCon 08 Mar 11, 2008
Oculus Innovative Sciences Schedules Conference Call Today to Discuss Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Feb 27, 2008
Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers Feb 27, 2008
Oculus Innovative Sciences to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference Feb 14, 2008
Oculus Innovative Sciences Announces Fiscal Third Quarter 2008 Quarterly Results and Clinical Update Feb 7, 2008
